Form 8-K - Current report:
SEC Accession No. 0001420720-25-000027
Filing Date
2025-06-18
Accepted
2025-06-18 07:22:17
Documents
13
Period of Report
2025-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20250617x8k.htm   iXBRL 8-K 29614
  Complete submission text file 0001420720-25-000027.txt   145730

Data Files

Seq Description Document Type Size
2 EX-101.SCH ibio-20250617.xsd EX-101.SCH 4112
3 EX-101.DEF ibio-20250617_def.xml EX-101.DEF 2849
4 EX-101.LAB ibio-20250617_lab.xml EX-101.LAB 16594
5 EX-101.PRE ibio-20250617_pre.xml EX-101.PRE 10908
15 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20250617x8k_htm.xml XML 4644
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 251055126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)